Cellular Biomedicine Group

136 articles about Cellular Biomedicine Group

• Cellular Biomedicine Group Featured on Wide World of Stocks Television

  5/12/2015

• Cellular Biomedicine Group Responds To Purported Class Action Lawsuit

  5/1/2015

• Cellular Biomedicine Group Appoints Two New Members To Scientific Advisory Board

  4/30/2015

• Cellular Biomedicine Group To Present Cancer CAR-T CD30 Therapy Clinical Development Program At The 10th Annual World Stem Cells & Regenerative Medicine Congress In London, UK

  4/27/2015

• Silicon Valley's Cellular Biomedicine Group Expands in Beijing With New Facility and Plans to Hire

  4/22/2015

• Cellular Biomedicine Group Engages Huntsworth Health To Build Global KOL Advocacy For Knee Osteoarthritis Stem Cell Rejoin(TM) Clinical Trials

  4/20/2015

• Cellular Biomedicine Group To Present At 10th Annual World Stem Cells & Regenerative Medicine Congress In London, UK

  4/17/2015

• Cellular Biomedicine Group Announces Participation In Jefferies and Co. 2015 Global Healthcare Conference

  4/16/2015

• Cellular Biomedicine Group Upgraded To NASDAQ Global Market

  4/10/2015

• Cellular Biomedicine Group To Present At Chinabio Partnering Forum In Shanghai On April 16, 2015

  4/10/2015

• Cellular Biomedicine Group Responds To False Statements And Allegations Made By Short Seller

  4/8/2015

• Cellular Biomedicine Group Hosts Open House Titled "Advancing Solutions To Cancerous And Degenerative Straits" On April 17, 2015

  4/8/2015

• Cellular Biomedicine Group Announces Closing Of $19.6 Million Private Placement Offering

  4/7/2015

• Cellular Biomedicine Group's Shanghai Facility Passes Fourth Consecutive CFDA Inspection

  4/6/2015

• Cellular Biomedicine Group Reports Full-Year And Fourth Quarter 2014 Financial Results

  3/31/2015

• Cellular Biomedicine Group Announces Phase I Results From CAR-T Immuno-Oncology Clinical Development Programs

  3/25/2015

• Cellular Biomedicine Group Announces Interim Results From Phase IIb Clinical Trial For Knee Osteoarthritis Stem Cell Rejoin Therapy

  3/25/2015

• Cellular Biomedicine Group To Present Osteoarthritis Stem Cell Rejoin Therapy And Cancer CAR-T Therapy Clinical Development Programs At The 2015 Annual Regen Med Investor Day

  3/18/2015

• Week in Review: Cellular Biomedicine Group In-Licenses Cancer Immunotherapy From China

  2/16/2015

• Cellular Biomedicine Group Acquiring Chinese PLA General Hospital's CAR-T (CD19/CD20/CD30/EGFR) Immuno-Oncology Technology And Clinical Data

  2/9/2015